help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vidal, R.
Right arrow Articles by Wisniewski, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vidal, R.
Right arrow Articles by Wisniewski, T.

American Journal of Pathology, Vol 148, 361-366, Copyright © 1996 by American Society for Investigative Pathology


REGULAR ARTICLES

Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G)

R Vidal, F Garzuly, H Budka, M Lalowski, RP Linke, F Brittig, B Frangione and T Wisniewski
Department of Pathology, New York University Medical Center, NY 10016, USA.

We describe a novel transthyretin mutation at codon 18 where Asp is replaced by Gly (D18G) in a Hungarian kindred. This mutation is associated with meningocerebrovascular amyloidosis, producing dementia, ataxia, and spasticity. Fifty different transthyretin mutations are related to amyloid deposition, typically producing a peripheral neuropathy or cardiac dysfunction. These symptoms are absent in this family. Up to now, amyloid-beta (A beta), cystatin C, and prion proteins have been known to be deposited as amyloid in the brain, leading to stroke or dementia. With this report we establish that transthyretin amyloid deposition can also produce central nervous system dysfunction as the major clinical symptom.


This article has been cited by other articles:


Home page
NeurologyHome page
M. Nakamura, T. Yamashita, M. Ueda, K. Obayashi, T. Sato, T. Ikeda, Y. Washimi, T. Hirai, Y. Kuwahara, M. T. Yamamoto, et al.
Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis
Neurology, October 11, 2005; 65(7): 1051 - 1056.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. M. Remes, S. Finnila, H. Mononen, H. Tuominen, R. Takalo, R. Herva, and K. Majamaa
Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathy
Neurology, July 27, 2004; 63(2): 234 - 240.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. Ellie, F. Camou, A. Vital, C. Rummens, G. Grateau, M. Delpech, and S. Valleix
Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu)
Neurology, July 10, 2001; 57(1): 135 - 137.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. GHISO, R. VIDAL, A. ROSTAGNO, S. MEAD, T. REVESZ, G. PLANT, and B. FRANGIONE
A Newly Formed Amyloidogenic Fragment due to a Stop Codon Mutation Causes Familial British Dementia
Ann. N.Y. Acad. Sci., April 1, 2000; 903(1): 129 - 137.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
P. BURGERMEISTER, M. E. CALHOUN, D. T. WINKLER, and M. JUCKER
Mechanisms of Cerebrovascular Amyloid Deposition: Lessons from Mouse Models
Ann. N.Y. Acad. Sci., April 1, 2000; 903(1): 307 - 316.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Mascalchi, F. Salvi, M. G. Pirini, A. D'Errico, A. Ferlini, F. Lolli, R. Plasmati, C. Tessa, N. Villari, and C. A. Tassinari
Transthyretin amyloidosis and superficial siderosis of the CNS
Neurology, October 22, 1999; 53(7): 1498 - 1498.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
T. Uemichi, R. J. Uitti, A. H. Koeppen, J. R. Donat, and M. D. Benson
Oculoleptomeningeal Amyloidosis Associated With a New Transthyretin Variant Ser64
Arch Neurol, September 1, 1999; 56(9): 1152 - 1155.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Brett, M. R. Persey, M. M. Reilly, T. Revesz, D. R. Booth, S. E. Booth, P. N. Hawkins, M. B. Pepys, and J. A. Morgan-Hughes
Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis
Brain, February 1, 1999; 122(2): 183 - 190.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. O. Weller, A. Massey, T. A. Newman, M. Hutchings, Y.-M. Kuo, and A. E. Roher
Cerebral Amyloid Angiopathy : Amyloid ß Accumulates in Putative Interstitial FluidDrainage Pathways in Alzheimer's Disease
Am. J. Pathol., September 1, 1998; 153(3): 725 - 733.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Miravalle, T. Tokuda, R. Chiarle, G. Giaccone, O. Bugiani, F. Tagliavini, B. Frangione, and J. Ghiso
Substitutions at Codon 22 of Alzheimer's Abeta Peptide Induce Diverse Conformational Changes and Apoptotic Effects in Human Cerebral Endothelial Cells
J. Biol. Chem., August 25, 2000; 275(35): 27110 - 27116.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Vidal, T. Revesz, A. Rostagno, E. Kim, J. L. Holton, T. Bek, M. Bojsen-Moller, H. Braendgaard, G. Plant, J. Ghiso, et al.
A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred
PNAS, April 25, 2000; 97(9): 4920 - 4925.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.